Tobacco and Research Funds

The article "Tobacco Settlement: Where's the Money?"1 brings up many important issues related to the allocation of state tobacco settlement funds. What the article did not mention, though, was that the public strongly supports spending the tobacco settlement funds on medical research. Ninety-one percent of those polled this year by Research!America, a nonprofit education and advocacy organization, favored spending a portion of the tobacco settlement funds on medical research. The same poll

Written byMatthew Bowdy
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The article "Tobacco Settlement: Where's the Money?"1 brings up many important issues related to the allocation of state tobacco settlement funds. What the article did not mention, though, was that the public strongly supports spending the tobacco settlement funds on medical research.

Ninety-one percent of those polled this year by Research!America, a nonprofit education and advocacy organization, favored spending a portion of the tobacco settlement funds on medical research. The same poll indicates that 84 percent support spending the settlement on youth antismoking education, the result of public health and behavioral health research.

Public support for spending the tobacco settlement funds on research demonstrates confidence in the researchers who are working to unlock the secrets of illnesses such as cancer and heart disease. Given that only 1 percent of the federal budget is spent on research and prevention for all diseases and disabilities, support for research at the state level ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies